The pursuit of “normalcy” has seriously led some scientists astray and there is no better example than the recent microbiome studies that have drawn great attention in the media. I found one aspect of their study design profoundly disturbing. First to my core question. Is there even such as thing as a normal person? As […]
The FDA has been busy with stem cell-related activities this spring. Busier than publicly apparent. Very busy, indeed! Earlier, I reported that they issued a warning letter to cosmetician to the stars, Dr. LookGood, as well as one to another doc selling stem cell therapies. Now it seems apparent that even more is going on
FDA visits both ICMS and reportedly Celltex: the scoop! Read More »
I recently did a post on the top 10 cancer myths out there and got some great feedback including some readers pointing out additional important myths. Here are some additional cancer myths. 1) The government and/or big pharma have cures for cancer, but they are hiding them from us so they can make more money
More cancer myths including some biggies Read More »
Cancer invokes powerful feelings so it is not surprising that there are a lot of harmful myths and urban legends out there about it. As a cancer researcher and cancer survivor, I can see it from both the biomedical research side and the patient side. Here’s my top 10 list of myths & legends about
Harmful cancer myths & urban legends Read More »
Today, an authoritative article was published in the prestigious New England Journal of Medicine (NEJM) that included some of the most comprehensive polling of attitudes in the U.S. and around the world on embryonic stem cell (ESC) research. Their findings indicate very widespread and deep support for ESC research around the globe including in the U.S. and
Periodically we do updates on the iPS cell field and now seems like a good time. Where do things stand? Here’s my top 5 list of action items for the iPS cell field in the coming year. 5.) Methods on the brain. A significant fraction, some would argue too high a fraction, of iPS cell papers
Top 5 iPS cell action items Read More »
Monday I did a post in response to an item that appeared in the Secondhand Smoke Blog by Wesley J. Smith where he invoked the opponents of ESC research favorite term to contrast so-called adult stem cell research with ESC research. In addition, he implied that George W. Bush deserved some of the credit for
Lessons from getting attacked by ESC research opponents Read More »
This is just the first in a series “Tales from the hood” about the stories of the stem cell scientists at the front lines of research. What really goes on in labs? After spending nearly half of my life being a scientist in one form or another including much time studying stem cells, I have
Tales from the Hood: what really goes on in research labs? Read More »
It has been a week to think about mentors and I posted somewhat autobiographically on how to find and be a good mentor a few days ago. Also along these lines, I asked one of the great mentors of all time, Irv Weissman, about his early career and who were the mentors that made the
Periodically we do updates on the iPS cell field and now seems like a good time. Where do things stand? Here’s my top 5 list of action items for the iPS cell field in the coming year. 5.) Methods on the brain. A significant fraction, some would argue too high a fraction, of iPS cell
Key iPS cell action items Read More »